Pregnant Women Injected With Banned, Blacklisted Pharma Company’s Shot; Five Women Lose Memory And..

In a shocking incident in Gujarat, five pregnant women reportedly lost their memory after receiving injections from a blacklisted pharmaceutical company. The case of gross negligence occurred at Sanjay Gandhi Medical College in Rewa. According to reports, the women were administered a medicine that had already been banned and blacklisted. Following the injection, all five women began exhibiting symptoms of memory loss. An initial investigation suggests the injection was mistakenly issued by the hospital’s storekeeper.

The First Complaint Came From Vidisha

A complaint regarding this injection was first received from Vidisha Medical College in October 2024, after which the medicine was banned. Gujarat-based Radiant Parenterals Limited company was officially blacklisted following the report in December. Reports suggests that the pharmacist had issued the banned medicine, and appropriate action has been taken against him.

Gujarat-based Radiant Parenterals Limited

The storekeeper has been suspended in connection with the incident, but no action has been taken against other officials so far. Due to this negligence, the pharmaceutical company has also been fined and blacklisted. The incident occurred at Sanjay Gandhi Medical College in Rewa.

What Happened At Sanjay Gandhi Medical College

At Sanjay Gandhi Medical College in Rewa, five pregnant women were administered an anesthesia injection manufactured by Gujarat-based Radiant Parenterals Limited. The company had already been blacklisted in December due to poor quality standards of its injections.

Banned Injection Issued By Storekeeper

The investigation revealed that hospital storekeeper Praveen Upadhyay mistakenly issued the banned injection, leading to his suspension. However, despite the gravity of the incident, no action was taken against other responsible officials. The probe also uncovered serious lapses in medicine storage—temperature was not properly monitored, inventory records were poorly maintained, and expired or substandard drugs were stored alongside approved ones.

Gujarat-based Radiant Parenterals Limited Banned For 5 Years

The company has been debarred from undertaking any government contracts for five years and blacklisted for two years. Additionally, a fine of ₹3.01 lakh has been imposed on the company. The use of the injection produced by Radiant Parenterals Limited was banned.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’